Initial study on a comprehensive strategy for female patients with bladder pain syndrome
10.3969/j.issn.1009-8291.2023.02.015
- VernacularTitle:女性膀胱疼痛综合征15例综合治疗初探
- Author:
Haiqi WU
1
;
Hai XU
2
;
Yalikun YIERFAN
2
;
Batur JESUR
2
;
Yingguo GAN
1
;
Zhenyu TAN
1
;
Li LU
1
Author Information
1. Department of Rectal Surgery, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, National Key Clinical Specialty, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510655
2. Department of Urology, The First People’s Hospital of Kashgar Prefecture, Kashgar 844000, China
- Publication Type:Journal Article
- Keywords:
bladder pain syndrome;
treatment strategy;
bladder hydrodistension;
intravesical therapy;
transurethral resection
- From:
Journal of Modern Urology
2023;28(2):149-152
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To explore the efficacy of a comprehensive treatment strategy of bladder hydrodistension, transurethral resection of bladder lesions and triple drug instillation in patients with painful bladder syndrome (BPS). 【Methods】 A total of 15 female BPS patients treated during Jan.2020 and Oct.2021 were enrolled. All patients received bladder hydrodistension and transurethral resection. After operation, intravesical instillation of a triple-drug mixture (2% lidocaine hydrochloride 20 mL, heparin sodium 25 000 U, and dexamethasone 10 mg) was administered once a day for 5 days, and then once per week for 4 weeks. The Visual Analogue Scale (VAS) score, quality of sexual life, health-related quality of life, and self-rating anxiety scale score were compared before treatment and 1, 4 and 12 weeks after treatment. The complications were recorded. 【Results】 All patients completed the treatment. Of 14 patients, the VAS score and self-rating anxiety scale score were lower in week 1, 4 and 12 after treatment, while the health-related quality of life score increased. One patient’s symptoms remained unchanged. The VAS score decreased from (5.47±1.81) to (1.87±1.51) (P<0.05), and the self-rating anxiety scale score decreased from (18.13±8.64) to (6.33±8.22) (P<0.05). The score of health-related quality of life increased from (24.47±5.41) to (31.53±6.49) (P<0.05). 【Conclusion】 The comprehensive strategy is effective in the treatment of bladder pain syndrome, which can relieve pain symptoms and improve patients’ quality of life.
